Aishwarya Joshi

Fellow, Vitreoretinal Services, Narayana Nethralaya, Bangalore

1 article

Dr. Aishwarya Joshi completed MBBS (2012-2018) and DNB Ophthalmology (2018-2021) from K J Somaiya Medical College and Research centre, Mumbai. She has presented at regional and national conferences like AIOC, RetNet and BOA. She also actively participated in a yearlong programme for ocular screening of leprosy patients. She have been a part of a study for managing amblyopia with the use of novel 'occlutab' in a Japan-India Joint research venture in conjunction with Kitasato University, Tokyo and National University of Electro-Communications in Tokyo, for which the group were also invited to Tokyo for an academic workshop. She is currently pursuing a fellowship in Vitreoretina at Narayana Nethralaya, Bangalore.

  1. Articles 13 Feb 2023 15 min read

    Optical Coherence Tomography Biomarkers in Diabetic Macular Edema

    One of the major microvascular complications of diabetes mellitus is diabetic retinopathy. Diabetic macular edema (DME) and proliferative diabetic retinopathy are the most common causes of vision loss in diabetic retinopathy. Pathogenesis of DME: A simplified understanding of the pathogenesis of DME formation is depicted in Figure 1: The role of vascular endothelial growth factor (VEGF) and inflammation in the pathogenesis of DME is depicted in Figure 2: OCT is a non-invasive imaging technique that is widely used in routine retina practice to obtain a high-definition cross section of all retinal layers and to measure their thickness. Recent advances in OCT imaging, such as the introduction of spectral-domain and swept source-based optical coherence tomography (OCT) and enhanced depth imaging, have enabled clinicians to detect and understand the various aspects of DME formation and treatment. This article will discuss the role of various OCT imaging biomarkers in identifying diabetic ma

    Dr. Ramesh Venkatesh, MS, FMRF, FVRF · Aishwarya Joshi · +1 other